Published in
American Association for the Advancement of Science, Science Translational Medicine, 610(13), 2021
DOI: 10.1126/scitranslmed.abf0376
Links
Tools
Anti-latent TGFβ binding protein 4 antibody improves muscle function and reduces muscle fibrosis in muscular dystrophy
Journal article published in 2021 by
Alexis R. Demonbreun 
,
Katherine S. Fallon ,
Claire C. Oosterbaan ,
Lauren A. Vaught ,
Nina L. Reiser ,
Elena Bogdanovic,
Matthew P. Velez ,
Isabella M. Salamone ,
Patrick G. T. Page,
Michele Hadhazy ,
Mattia Quattrocelli,
David Y. Barefield ,
Lauren D. Wood ,
J. Patrick Gonzalez,
Carl Morris
and other authors.
,
Katherine S. Fallon ,
Claire C. Oosterbaan ,
Lauren A. Vaught ,
Nina L. Reiser ,
Elena Bogdanovic,
Matthew P. Velez ,
Isabella M. Salamone ,
Patrick G. T. Page,
Michele Hadhazy ,
Mattia Quattrocelli,
David Y. Barefield ,
Lauren D. Wood ,
J. Patrick Gonzalez,
Carl Morris
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
A high-affinity antibody to LTBP4 stabilizes muscle and promotes improved muscle function in mouse models of muscular dystrophy.